Stammdaten
Sigyn Therapeutics, Inc. operates as a development-stage therapeutic technology company. It offers Sigyn Therapy, a blood purification technology to overcome the limitations of previous drugs and devices to treat life-threatening inflammatory disorders, including sepsis, the cause of hospital deaths. The company also engages in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; CytoVesicles; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. The company is headquartered in San Diego, California.
Unternehmen & Branche
| Name | Sigyn Therapeutics, Inc. |
|---|---|
| Ticker | SIGY |
| CIK | 0001642159 |
| Sektor | Healthcare |
| Industrie | Biotechnology |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | – |
| Marktkapitalisierung | 72.242 USD |
| Beta | -0,49 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-09-30 | 10-Q | -578,503 | -0.36 | 135,571 | -5,917,209 | |
| 2025-06-30 | 10-Q | -1,451,187 | -0.90 | 51,759 | -5,437,629 | |
| 2025-03-31 | 10-Q | -668,564 | -0.42 | 244,309 | -4,945,207 | |
| 2024-12-31 | 10-K | -3,340,212 | -2.51 | 213,719 | -4,457,624 | |
| 2024-09-30 | 10-Q | -1,196,923 | -0.94 | 427,438 | -3,922,586 | |
| 2024-06-30 | 10-Q | -862,383 | -0.70 | 320,165 | -3,672,141 | |
| 2024-03-31 | 10-Q | -758,088 | -0.62 | 323,295 | -4,021,254 | |
| 2023-12-31 | 10-K | -4,145,936 | -3.77 | 321,806 | -3,412,500 | |
| 2023-09-30 | 10-Q | -905,726 | -0.82 | 387,223 | -3,575,671 | |
| 2023-06-30 | 10-Q | -723,124 | -0.67 | 361,817 | -3,042,218 | |
| 2023-03-31 | 10-Q | -1,341,036 | -1.39 | 660,447 | -2,346,038 | |
| 2022-12-31 | 10-K | -2,929,817 | -3.13 | 332,879 | -1,903,240 | |
| 2022-09-30 | 10-Q | -726,509 | -0.02 | 362,273 | -1,742,102 | |
| 2022-06-30 | 10-Q | -666,325 | -0.02 | 395,908 | -1,183,161 | |
| 2022-03-31 | 10-Q | -678,046 | 447,414 | -731,569 | ||
| 2021-12-31 | 10-K | -3,004,619 | 710,259 | -264,584 | ||
| 2021-09-30 | 10-Q | -665,904 | 1,440,823 | 358,232 | ||
| 2021-06-30 | 10-Q | -649,861 | 1,992,559 | 977,137 | ||
| 2021-03-31 | 10-Q | -461,682 | 608,960 | -80,253 | ||
| 2020-12-31 | 10-K | -1,259,590 | 694,082 | 99,179 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.